The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1

Molecular Biology of the Cell

Volumn 27, Issue 24, 2016, Pages 3841-3854

  Rataj, Felicitas ^a   Planel, Séverine ^a   Desroches Castan, Agnès ^a   Le Douce, Juliette ^a   Lamribet, Khadija ^a   Denis, Josiane ^a   Feige, Jean Jacques ^a   Cherradi, Nadia ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRATE RESPONSE FACTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; RNA BINDING PROTEIN; SERINE; 3' UNTRANSLATED REGION; BRF1 PROTEIN, HUMAN; CYCLIC AMP; DCP1A PROTEIN, HUMAN; RIBONUCLEASE; RNA RECOGNITION MOTIF PROTEIN; SIGNAL PEPTIDE; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSACTIVATOR PROTEIN; TRISTETRAPROLIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HALF LIFE TIME; IMMUNODETECTION; IN VITRO STUDY; IN VIVO STUDY; KINASE ASSAY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA BINDING; RNA DEGRADATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; 3' UNTRANSLATED REGION; ANIMAL; CELL CULTURE TECHNIQUE; CHLOROCEBUS AETHIOPS; CV-1 CELL LINE; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN DOMAIN; RNA STABILITY;

3' UNTRANSLATED REGIONS; ANIMALS; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDORIBONUCLEASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA RECOGNITION MOTIF PROTEINS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANS-ACTIVATORS; TRISTETRAPROLIN;

EID: 85001967702     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E16-06-0379     Document Type: Article

References (47)

1. Baou M, Jewell A, Murphy JJ (2009). TIS11 family proteins and their roles in posttranscriptional gene regulation. J Biomed Biotechnol 2009, 634520.
2. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR, Turner M (2006). The RNA binding protein Zfp36l1 is required for normal vascularisation and posttranscriptionally regulates VEGF expression. Dev Dyn 235, 3144-3155.
3. Benjamin D, Schmidlin M, Min L, Gross B, Moroni C (2006). BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol Cell Biol 26, 9497-9507.
4. Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Richfield EK, Lai WS (2005). Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod 73, 297-307.
5. Briata P, Chen CY, Ramos A, Gherzi R (2013). Functional and molecular insights into KSRP function in mRNA decay. Biochim Biophys Acta 1829, 689-694.
6. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR (2006). Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 26, 2408-2418.
7. Brooks SA, Blackshear PJ (2013). Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta 1829, 666-679.
8. Cao H, Deterding LJ, Blackshear PJ (2014). Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry. PLoS One 9, e100977.
9. Carballo E, Lai WS, Blackshear PJ (1998). Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281, 1001-1005.
10. Carballo E, Lai WS, Blackshear PJ (2000). Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95, 1891-1899.
11. Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ, Cherradi N (2011). Hypoxia-inducible factor-1alpha mRNA: a new target for destabilization by tristetraprolin in endothelial cells. Mol Biol Cell 22, 3366-3378.
12. Cherradi N, Lejczak C, Desroches-Castan A, Feige JJ (2006). Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin. Mol Endocrinol 20, 916-930.
13. Chinn AM, Ciais D, Bailly S, Chambaz E, LaMarre J, Feige JJ (2002). Identification of two novel ACTH-responsive genes encoding manganesedependent superoxide dismutase (SOD2) and the zinc finger protein TIS11b [tetradecanoyl phorbol acetate (TPA)-inducible sequence 11b]. Mol Endocrinol 16, 1417-1427.
14. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, Sturgill TW (2004). MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279, 10176-10184.
15. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ (2004). Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23, 8673-8680.
16. Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J (2011). Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol 31, 256-266.
17. Corps AN, Pascall JC, Hadfield KM, Brown KD (1995). Identification of a functional promoter element in the 5flanking region of the rat cMG1/ TIS11b gene. Biochem J 311, 251-258.
18. Duan H, Cherradi N, Feige JJ, Jefcoate C (2009). cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b. Mol Endocrinol 23, 497-509.
19. Duperray A, Chambaz EM (1980). Effect of prostaglandin E1 and ACTH on proliferation and steroidogenic activity of bovine adreno-cortical cells in primary culture. J Steroid Biochem 13, 1359-1364.
20. Fabian MR, Frank F, Rouya C, Siddiqui N, Lai WS, Karetnikov A, Blackshear PJ, Nagar B, Sonenberg N (2013). Structural basis for the recruitment of the human CCR4-NOT deadenylase complex by tristetraprolin. Nat Struct Mol Biol 20, 735-739.
21. Fan XC, Steitz JA (1998). Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17, 3448-3460.
22. Fenger-Gron M, Fillman C, Norrild B, Lykke-Andersen J (2005). Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell 20, 905-915.
23. Garneau NL, Wilusz J, Wilusz CJ (2007). The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 8, 113-126.
24. Goldstrohm AC, Wickens M (2008). Multifunctional deadenylase complexes diversify mRNA control. Nat Rev Mol Cell Biol 9, 337-344.
25. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, Peterson TR, Choi Y, Gray NS, Yaffe MB, et al. (2011). The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322.
26. Kim TW, Yim S, Choi BJ, Jang Y, Lee JJ, Sohn BH, Yoo HS, Yeom YI, Park KC (2010). Tristetraprolin regulates the stability of HIF-1alpha mRNA during prolonged hypoxia. Biochem Biophys Res Commun 391, 963-968.
27. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M (1999). MAPKAP kinase 2 is essential for LPS-induced TNFalpha biosynthesis. Nat Cell Biol 1, 94-97.
28. Lykke-Andersen J, Wagner E (2005). Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev 19, 351-361.
29. Maitra S, Chou CF, Luber CA, Lee KY, Mann M, Chen CY (2008). The AUrich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA 14, 950-959.
30. Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, Dean JL (2010). MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J Biol Chem 285, 27590-27600.
31. Meisner NC, Filipowicz W (2010). Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 700, 106-123.
32. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD, Holtmann H, Kollias G, Gaestel M (2002). MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 277, 3065-3068.
33. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR (2005). Tristetraprolin down-regulates IL-2 gene expression through AUrich element-mediated mRNA decay. J Immunol 174, 953-961.
34. Planel S, Salomon A, Jalinot P, Feige JJ, Cherradi N (2010). A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1. Oncogene 29, 5989-6003.
35. Sandler H, Kreth J, Timmers HT, Stoecklin G (2011). Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res 39, 4373-4386.
36. Schmidlin M, Lu M, Leuenberger SA, Stoecklin G, Mallaun M, Gross B, Gherzi R, Hess D, Hemmings BA, Moroni C (2004). The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J 23, 4760-4769.
37. She M, Decker CJ, Svergun Di, Round A, Chen N, Muhlrad D, Parker R, Song H (2008). Structural basis of dcp2 recognition and activation by dcp1. Mol Cell 29, 337-349.
38. Sinha S, Dutta S, Datta K, Ghosh AK, Mukhopadhyay D (2009). Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia. J Biol Chem 284, 32610-32618.
39. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P (2004). MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23, 1313-1324.
40. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P (2008). Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283, 11689-11699.
41. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, Shelley WC, Richfield EK, Ray MK, Yoder MC, et al. (2009). Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 114, 2401-2410.
42. Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP (2007). Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 282, 3766-3777.
43. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman Di, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ (1996). A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445-454.
44. van Dijk E, Cougot N, Meyer S, Babajko S, Wahle E, Seraphin B (2002). Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J 21, 6915-6924.
45. Venigalla RK, Turner M (2012). RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways. Front Immunol 3, 398.
46. Viengchareun S, Lema I, Lamribet K, Keo V, Blanchard A, Cherradi N, Lombes M (2014). Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control. J Am Soc Nephrol 25, 2213-2221.
47. White EJ, Brewer G, Wilson GM (2013). Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta 1829, 680-688.